GLOBAL LEADERS IN
Based in Helsinki, Finland, MEGIN is the global leader for Magnetoencephalography (MEG) technology, a non-invasive, functional brain mapping solution for the diagnostic workup, treatment strategy and intervention of neurological conditions. Through innovation and passionate exploration of the endless possibilities with MEG, specialists from close to one hundred sites from around the world have used our MEG technology to study pathological and eloquent areas of the brain in patients diagnosed with neurological disorders.
MEGIN is a Croton Healthcare Company
MEGIN Spotlight – Dr. Stefan Rampp
MEGIN Spotlight invited Dr Stefan Rampp from University Hospital in Erlangen to share his knowledge and experience using Magnetoencephalography (MEG) in treatment of patients diagnosed with neurological disorders.